Market Research

Genomics Personalized Health Market (Technology: NGS Platform, RT-PCR, Microarray, Genetic Analyzer, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034

Best Price Guarantee Length Publisher Published Date SKU
from $5,795 180 Pages Transparency Market Research Pvt. Ltd. April, 2024 TNPR18827828
Best Price Guarantee
Price from $5,795
Length 180 Pages
Publisher Transparency Market Research Pvt. Ltd.
Published Date April, 2024
SKU TNPR18827828

Genomics Personalized Health Market (Technology: NGS Platform, RT-PCR, Microarray, Genetic Analyzer, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034


Genomics Personalized Health Market – Scope of Report

TMR’s report on the global genomics personalized health market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global genomics personalized health market for the period 2018–2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global genomics personalized health market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the genomics personalized health market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global genomics personalized health market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global genomics personalized health market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global genomics personalized health market.

The report delves into the competitive landscape of the global genomics personalized health market. Key players operating in the global genomics personalized health market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global genomics personalized health market profiled in this report.

Key Questions Answered in Global genomics personalized health Market Report
  • What is the sales/revenue generated by genomics personalized health across all regions during the forecast period?
  • What are the opportunities in the global genomics personalized health market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2034?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?
Genomics Personalized Health Market – Research Objectives and Research Approach

The comprehensive report on the global genomics personalized health market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global genomics personalized health market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global genomics personalized health market.


1. Preface
  1.1. Market Definition and Scope
  1.2. Market Segmentation
  1.3. Key Research Objectives
  1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Genomics Personalized Health Market
4. Market Overview
  4.1. Introduction
  4.1.1. Product Definition
  4.1.2. Industry Evolution/Developments
  4.2. Overview
  4.3. Market Dynamics
  4.3.1. Drivers
  4.3.2. Restraints
  4.3.3. Opportunities
  4.4. Genomics Personalized Health Market Analysis and Forecast, 2020-2034
5. Key Insights
  5.1. Pipeline Analysis
  5.2. Key Product /Brand Analysis
  5.3. Key Mergers & Acquisitions
  5.4. COVID-19 Pandemic Impact on Industry
6. Global Genomics Personalized Health Market Analysis and Forecast, By Technology
  6.1. Introduction & Definition
  6.2. Key Findings/Developments
  6.3. Market Value Forecast, By Technology, 2020-2034
  6.3.1. NGS Platform
  6.3.2. RT-PCR
  6.3.3. Microarray
  6.3.4. Genetic Analyzer
  6.3.5. Others
  6.4. Market Attractiveness Analysis, By Technology
7. Global Genomics Personalized Health Market Analysis and Forecast, by Test Type
  7.1. Introduction & Definition
  7.2. Key Findings/Developments
  7.3. Market Value Forecast, by Test Type, 2020-2034
  7.3.1. Oncology Testing
  7.3.2. Infectious Disease Testing
  7.3.3. Orphan Disease Testing
  7.3.4. Autoimmune Disease Testing
  7.3.5. Obstetrics Testing
  7.3.6. Others
  7.4. Market Attractiveness Analysis, by Test Type
8. Global Genomics Personalized Health Market Analysis and Forecast, by End-user
  8.1. Introduction & Definition
  8.2. Key Findings/Developments
  8.3. Market Value Forecast, by End-user, 2020-2034
  8.3.1. Academics & Research Institutes
  8.3.2. Diagnostic Centers
  8.3.3. Others
  8.4. Market Attractiveness Analysis, by End-user
9. Global Genomics Personalized Health Market Analysis and Forecast, by Region
  9.1. Key Findings
  9.2. Market Value Forecast, by Region, 2020-2034
  9.2.1. North America
  9.2.2. Europe
  9.2.3. Asia Pacific
  9.2.4. Latin America
  9.2.5. Middle East & Africa
  9.3. Market Attractiveness Analysis, by Region
10. North America Genomics Personalized Health Market Analysis and Forecast
  10.1. Introduction
  10.2. Key Findings
  10.3. Market Value Forecast, By Technology, 2020-2034
  10.3.1. NGS Platform
  10.3.2. RT-PCR
  10.3.3. Microarray
  10.3.4. Genetic Analyzer
  10.3.5. Others
  10.4. Market Value Forecast, by Test Type, 2020-2034
  10.4.1. Oncology Testing
  10.4.2. Infectious Disease Testing
  10.4.3. Orphan Disease Testing
  10.4.4. Autoimmune Disease Testing
  10.4.5. Obstetrics Testing
  10.4.6. Others
  10.5. Market Value Forecast, by End-user, 2020-2034
  10.5.1. Academics & Research Institutes
  10.5.2. Diagnostic Centers
  10.5.3. Others
  10.6. Market Value Forecast, by Country, 2020-2034
  10.6.1. U.S.
  10.6.2. Canada
  10.7. Market Attractiveness Analysis
  10.7.1. By Technology
  10.7.2. By Test Type
  10.7.3. By End-user
  10.7.4. By Country
11. Europe Genomics Personalized Health Market Analysis and Forecast
  11.1. Introduction
  11.2. Key Findings
  11.3. Market Value Forecast, By Technology, 2020-2034
  11.3.1. NGS Platform
  11.3.2. RT-PCR
  11.3.3. Microarray
  11.3.4. Genetic Analyzer
  11.3.5. Others
  11.4. Market Value Forecast, by Test Type, 2020-2034
  11.4.1. Oncology Testing
  11.4.2. Infectious Disease Testing
  11.4.3. Orphan Disease Testing
  11.4.4. Autoimmune Disease Testing
  11.4.5. Obstetrics Testing
  11.4.6. Others
  11.5. Market Value Forecast, by End-user, 2020-2034
  11.5.1. Academics & Research Institutes
  11.5.2. Diagnostic Centers
  11.5.3. Others
  11.6. Market Value Forecast, by Country/Sub-region, 2020-2034
  11.6.1. Germany
  11.6.2. U.K.
  11.6.3. France
  11.6.4. Italy
  11.6.5. Spain
  11.6.6. Rest of Europe
  11.7. Market Attractiveness Analysis
  11.7.1. By Technology
  11.7.2. By Test Type
  11.7.3. By End-user
  11.7.4. By Country/Sub-region
12. Asia Pacific Genomics Personalized Health Market Analysis and Forecast
  12.1. Introduction
  12.2. Key Findings
  12.3. Market Value Forecast, By Technology, 2020-2034
  12.3.1. NGS Platform
  12.3.2. RT-PCR
  12.3.3. Microarray
  12.3.4. Genetic Analyzer
  12.3.5. Others
  12.4. Market Value Forecast, by Test Type, 2020-2034
  12.4.1. Oncology Testing
  12.4.2. Infectious Disease Testing
  12.4.3. Orphan Disease Testing
  12.4.4. Autoimmune Disease Testing
  12.4.5. Obstetrics Testing
  12.4.6. Others
  12.5. Market Value Forecast, by Country/Sub-region, 2020-2034
  12.5.1. China
  12.5.2. Japan
  12.5.3. India
  12.5.4. Australia & New Zealand
  12.5.5. Rest of Asia Pacific
  12.6. Market Attractiveness Analysis
  12.6.1. By Technology
  12.6.2. By Test Type
  12.6.3. By End-user
  12.6.4. By Country/Sub-region
13. Latin America Genomics Personalized Health Market Analysis and Forecast
  13.1. Introduction
  13.2. Key Findings
  13.3. Market Value Forecast, By Technology, 2020-2034
  13.3.1. NGS Platform
  13.3.2. RT-PCR
  13.3.3. Microarray
  13.3.4. Genetic Analyzer
  13.3.5. Others
  13.4. Market Value Forecast, by Test Type, 2020-2034
  13.4.1. Oncology Testing
  13.4.2. Infectious Disease Testing
  13.4.3. Orphan Disease Testing
  13.4.4. Autoimmune Disease Testing
  13.4.5. Obstetrics Testing
  13.4.6. Others
  13.5. Market Value Forecast, by End-user, 2020-2034
  13.5.1. Academics & Research Institutes
  13.5.2. Diagnostic Centers
  13.5.3. Others
  13.6. Market Value Forecast, by Country/Sub-region, 2020-2034
  13.6.1. Brazil
  13.6.2. Mexico
  13.6.3. Rest of Latin America
  13.7. Market Attractiveness Analysis
  13.7.1. By Technology
  13.7.2. By Test Type
  13.7.3. By End-user
  13.7.4. By Country/Sub-region
14. Middle East & Africa Genomics Personalized Health Market Analysis and Forecast
  14.1. Introduction
  14.2. Key Findings
  14.3. Market Value Forecast, By Technology, 2020-2034
  14.3.1. NGS Platform
  14.3.2. RT-PCR
  14.3.3. Microarray
  14.3.4. Genetic Analyzer
  14.3.5. Others
  14.4. Market Value Forecast, by Test Type, 2020-2034
  14.4.1. Oncology Testing
  14.4.2. Infectious Disease Testing
  14.4.3. Orphan Disease Testing
  14.4.4. Autoimmune Disease Testing
  14.4.5. Obstetrics Testing
  14.4.6. Others
  14.5. Market Value Forecast, by End-user, 2020-2034
  14.5.1. Academics & Research Institutes
  14.5.2. Diagnostic Centers
  14.5.3. Others
  14.6. Market Value Forecast, by Country/Sub-region, 2020-2034
  14.6.1. GCC Countries
  14.6.2. South Africa
  14.6.3. Rest of Middle East & Africa
  14.7. Market Attractiveness Analysis
  14.7.1. By Technology
  14.7.2. By Test Type
  14.7.3. By End-user
  14.7.4. By Country/Sub-region
15. Competition Landscape
  15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
  15.2. Market Share Analysis, by Company (2023)
  15.3. Company Profiles
  15.3.1. QIAGEN
  15.3.1.1. Company Overview
  15.3.1.2. Product Portfolio
  15.3.1.3. SWOT Analysis
  15.3.1.4. Financial Overview
  15.3.1.5. Strategic Overview
  15.3.2. Illumina, Inc.
  15.3.2.1. Company Overview
  15.3.2.2. Product Portfolio
  15.3.2.3. SWOT Analysis
  15.3.2.4. Financial Overview
  15.3.2.5. Strategic Overview
  15.3.3. Thermo Fisher Scientific, Inc.
  15.3.3.1. Company Overview
  15.3.3.2. Product Portfolio
  15.3.3.3. SWOT Analysis
  15.3.3.4. Financial Overview
  15.3.3.5. Strategic Overview
  15.3.4. Bio-Rad Laboratories, Inc.
  15.3.4.1. Company Overview
  15.3.4.2. Product Portfolio
  15.3.4.3. SWOT Analysis
  15.3.4.4. Financial Overview
  15.3.4.5. Strategic Overview
  15.3.5. Hoffmann-La Roche AG
  15.3.5.1. Company Overview
  15.3.5.2. Product Portfolio
  15.3.5.3. SWOT Analysis
  15.3.5.4. Financial Overview
  15.3.5.5. Strategic Overview
  15.3.6. Lonza Group
  15.3.6.1. Company Overview
  15.3.6.2. Product Portfolio
  15.3.6.3. SWOT Analysis
  15.3.6.4. Financial Overview
  15.3.6.5. Strategic Overview
  15.3.7. Invitae Corp
  15.3.7.1. Company Overview
  15.3.7.2. Product Portfolio
  15.3.7.3. SWOT Analysis
  15.3.7.4. Financial Overview
  15.3.7.5. Strategic Overview
  15.3.8. Genetic Technologies Limited
  15.3.8.1. Company Overview
  15.3.8.2. Product Portfolio
  15.3.8.3. SWOT Analysis
  15.3.8.4. Financial Overview
  15.3.8.5. Strategic Overview
  15.3.9. Interleukin Genetics Inc.
  15.3.9.1. Company Overview
  15.3.9.2. Product Portfolio
  15.3.9.3. SWOT Analysis
  15.3.9.4. Financial Overview
  15.3.9.5. Strategic Overview
  15.3.10. Eastern Biotech and Life Sciences
  15.3.10.1. Company Overview
  15.3.10.2. Product Portfolio
  15.3.10.3. SWOT Analysis
  15.3.10.4. Financial Overview
  15.3.10.5. Strategic Overview
  15.3.11. DNA Genotek Inc.
  15.3.11.1. Company Overview
  15.3.11.2. Product Portfolio
  15.3.11.3. SWOT Analysis
  15.3.11.4. Financial Overview
  15.3.11.5. Strategic Overview
  15.3.12. uBiome, Inc.
  15.3.12.1. Company Overview
  15.3.12.2. Product Portfolio
  15.3.12.3. SWOT Analysis
  15.3.12.4. Financial Overview
  15.3.12.5. Strategic Overview
  15.3.13. XCode Life Sciences Private Limited
  15.3.13.1. Company Overview
  15.3.13.2. Product Portfolio
  15.3.13.3. SWOT Analysis
  15.3.13.4. Financial Overview
  15.3.13.5. Strategic Overview

$5,795
$8,795
$11,795

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings